Cargando…
Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
β-blockers is a vast group of antiarrhythmic drugs which differ in their pharmacokinetic and chemical properties. Some of them block β-adrenergic receptors selectively while the others work non-selectively. Consequently, they reduce the influence of the sympathetic nervous system on the heart, actin...
Autores principales: | Wołowiec, Łukasz, Grześk, Grzegorz, Osiak, Joanna, Wijata, Aleksandra, Mędlewska, Martyna, Gaborek, Patryk, Banach, Joanna, Wołowiec, Anna, Głowacka, Mariola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868422/ https://www.ncbi.nlm.nih.gov/pubmed/36699057 http://dx.doi.org/10.3389/fphar.2022.1043714 |
Ejemplares similares
-
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
por: Wołowiec, Łukasz, et al.
Publicado: (2023) -
Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
por: Wołowiec, Łukasz, et al.
Publicado: (2023) -
The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target
por: Wołowiec, Anna, et al.
Publicado: (2023) -
Alcohol and Cardiovascular Diseases—Do the Consumption Pattern and Dose Make the Difference?
por: Chudzińska, Małgorzata, et al.
Publicado: (2022) -
Catestatin as a New Prognostic Marker in Stable Patients with Heart Failure with Reduced Ejection Fraction in Two-Year Follow-Up
por: Wołowiec, Łukasz, et al.
Publicado: (2020)